Filing Details
- Accession Number:
- 0001415889-25-008274
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-17 21:04:15
- Reporting Period:
- 2025-03-13
- Filing Date:
- 2025-03-17
- Accepted Time:
- 2025-03-17 21:04:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1933414 | Mineralys Therapeutics Inc. | MLYS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1253170 | Srinivas Akkaraju | 628 Middlefield Road Palo Alto CA 94301 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-03-13 | 600,000 | $13.50 | 5,674,916 | No | 4 | P | Indirect | By Samsara BioCapital, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Samsara BioCapital, L.P. |
Footnotes
- Securities are directly held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.